skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 328  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents
Material Type:
Article
Add to My Research

2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents

Journal of the American College of Cardiology, 2016-07, Vol.68 (1), p.92-125 [Peer Reviewed Journal]

Copyright Elsevier Limited Jul 5, 2016 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2016.03.519 ;PMID: 27046161

Full text available

2
Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study
Material Type:
Article
Add to My Research

Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study

Journal of the American College of Cardiology, 2015-04, Vol.65 (15), p.1552-1561 [Peer Reviewed Journal]

Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2015.02.020 ;PMID: 25770315

Full text available

3
Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease: A Mendelian Randomization Analysis
Material Type:
Article
Add to My Research

Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease: A Mendelian Randomization Analysis

Journal of the American College of Cardiology, 2012-12, Vol.60 (25), p.2631-2639 [Peer Reviewed Journal]

2014 INIST-CNRS ;Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2012.09.017 ;PMID: 23083789 ;CODEN: JACCDI

Full text available

4
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
Material Type:
Article
Add to My Research

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Journal of the American College of Cardiology, 2021-08, Vol.78 (5), p.421-433 [Peer Reviewed Journal]

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0735-1097 ;ISSN: 1558-3597 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.04.102 ;PMID: 34325831

Full text available

5
Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial
Material Type:
Article
Add to My Research

Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial

Journal of the American College of Cardiology, 2016-02, Vol.67 (4), p.353-361 [Peer Reviewed Journal]

Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2015.10.077 ;PMID: 26821621

Full text available

6
Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk: A Randomized, Double-Blind, Placebo-Controlled Trial
Material Type:
Article
Add to My Research

Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk: A Randomized, Double-Blind, Placebo-Controlled Trial

Journal of the American College of Cardiology, 2013-12, Vol.62 (23), p.2178-2184 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2013.07.081 ;PMID: 24013058 ;CODEN: JACCDI

Full text available

7
Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial
Material Type:
Article
Add to My Research

Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial

Journal of the American College of Cardiology, 2020-05, Vol.75 (18), p.2297-2308 [Peer Reviewed Journal]

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2020.03.029 ;PMID: 32381160

Full text available

8
Cognition After Lowering LDL-Cholesterol With Evolocumab
Material Type:
Article
Add to My Research

Cognition After Lowering LDL-Cholesterol With Evolocumab

Journal of the American College of Cardiology, 2020-05, Vol.75 (18), p.2283-2293 [Peer Reviewed Journal]

2020 American College of Cardiology Foundation ;Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2020.03.039 ;PMID: 32381158

Full text available

9
Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial
Material Type:
Article
Add to My Research

Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial

Journal of the American College of Cardiology, 2020-05, Vol.75 (17), p.2110-2118 [Peer Reviewed Journal]

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2020.03.015 ;PMID: 32194196

Full text available

10
Lipoprotein(a) as a Potential Causal Genetic Risk Factor of Cardiovascular Disease: A Rationale for Increased Efforts to Understand its Pathophysiology and Develop Targeted Therapies
Material Type:
Article
Add to My Research

Lipoprotein(a) as a Potential Causal Genetic Risk Factor of Cardiovascular Disease: A Rationale for Increased Efforts to Understand its Pathophysiology and Develop Targeted Therapies

Journal of the American College of Cardiology, 2012-08, Vol.60 (8), p.716-721 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2012.04.038 ;PMID: 22898069 ;CODEN: JACCDI

Full text available

11
Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study
Material Type:
Article
Add to My Research

Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study

Journal of the American College of Cardiology, 2020-05, Vol.75 (20), p.2570-2584 [Peer Reviewed Journal]

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2020.03.025 ;PMID: 32234462

Full text available

12
Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk
Material Type:
Article
Add to My Research

Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk

Journal of the American College of Cardiology, 2020-09, Vol.76 (13), p.1507-1516 [Peer Reviewed Journal]

2020 American College of Cardiology Foundation ;Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2020.07.059 ;PMID: 32972526

Full text available

13
Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol
Material Type:
Article
Add to My Research

Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol

Journal of the American College of Cardiology, 2022-03, Vol.79 (11), p.1035-1046 [Peer Reviewed Journal]

2022 The Authors ;Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.12.032 ;PMID: 35300814

Full text available

14
Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease
Material Type:
Article
Add to My Research

Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease

Journal of the American College of Cardiology, 2020-05, Vol.75 (17), p.2122-2135 [Peer Reviewed Journal]

2020 American College of Cardiology Foundation ;Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2020.02.059 ;PMID: 32354380

Full text available

15
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee
Material Type:
Article
Add to My Research

2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee

Journal of the American College of Cardiology, 2022-10, Vol.80 (14), p.1366-1418 [Peer Reviewed Journal]

EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2022.07.006 ;PMID: 36031461

Full text available

16
PCSK9 R46L, Low-Density Lipoprotein Cholesterol Levels, and Risk of Ischemic Heart Disease: 3 Independent Studies and Meta-Analyses
Material Type:
Article
Add to My Research

PCSK9 R46L, Low-Density Lipoprotein Cholesterol Levels, and Risk of Ischemic Heart Disease: 3 Independent Studies and Meta-Analyses

Journal of the American College of Cardiology, 2010-06, Vol.55 (25), p.2833-2842 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jun 22, 2010 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2010.02.044 ;PMID: 20579540 ;CODEN: JACCDI

Full text available

17
Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia
Material Type:
Article
Add to My Research

Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia

Journal of the American College of Cardiology, 2016-06, Vol.67 (22), p.2578-2589 [Peer Reviewed Journal]

American College of Cardiology Foundation ;2016 American College of Cardiology Foundation ;Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jun 7, 2016 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2016.03.520 ;PMID: 27050191

Full text available

18
Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series
Material Type:
Article
Add to My Research

Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series

Journal of the American College of Cardiology, 2018-09, Vol.72 (10), p.1141-1156 [Peer Reviewed Journal]

Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Sep 4, 2018 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2018.06.046 ;PMID: 30165986

Full text available

19
The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): Final Results and the Impact of Medication Adherence, Dose, and Treatment Duration
Material Type:
Article
Add to My Research

The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): Final Results and the Impact of Medication Adherence, Dose, and Treatment Duration

Journal of the American College of Cardiology, 2010-06, Vol.55 (24), p.2721-2726 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jun 15, 2010 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2010.03.017 ;PMID: 20399059 ;CODEN: JACCDI

Full text available

20
Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations
Material Type:
Article
Add to My Research

Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations

Journal of the American College of Cardiology, 2017-08, Vol.70 (9), p.1162-1170 [Peer Reviewed Journal]

2017 American College of Cardiology Foundation ;Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Aug 29, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2017.06.058 ;PMID: 28838366

Full text available

Results 1 - 20 of 328  for All Library Resources

Results 1 2 3 4 5 next page

Searching Remote Databases, Please Wait